AMA Ed Hub Logo

Learn more on prescription drugs from AMA Ed Hub™
Red JAMA Logo

Learn more on prescription drugs from JAMA Network™
2025 Annual Meeting of the HOD

Learn more on prescription drugs from PolicyFinder
United States Adopted Names Council

United States Adopted Names (USAN)
Clear Search
Richard Deem, the AMA’s senior vice president for advocacy
·
4 Min Read

5 ways the midterms shook up the U.S. health care agenda for 2019

Prescription-drug pricing, gun violence and ACA-stabilization efforts are among the issues that could see new life next year.

Access to Care
Two delegates consulting at 2018 AMA Interim Meeting
·
2 Min Read

AMA: Fix hospital eligibility criteria for drug-discount program

Outpatient charity care should determine 340B program eligibility as part of a revised formula for the federal program, physicians say.

Behavioral Health
·
4 Min Read

AMA policy on in-person importation of prescription drugs from Canada

Physicians at the Interim Meeting of the AMA adopted policy supporting in-person importation of prescription drugs from licensed Canadian pharmacies.

Press Releases
Presenting at a panel
·
2 Min Read

AMA backs in-person import of Canadian Rx if safety is assured

Allowing the practice offers patients an option to lower patient out-of-pocket spending on prescription drugs, which addresses a barrier to medication adherence: unaffordability.

Behavioral Health
·
8 Min Read

Nov. 1, 2018: National Advocacy Update

Trump administration on drug prices, FTC and insulin prices and more in the latest from AMA's national advocacy news.

Advocacy Update
·
1 Min Read

AMA statement on president’s plan for prescription drugs

Physicians share their patients’ concerns with the cost of prescription drugs. We appreciate the Trump Administration addressing this important issue.

Press Releases
·
10 Min Read

Oct. 18, 2018: National Advocacy Update

Drug prices in TV ads, Surgeon General's opioid report and more in the latest AMA national health care advocacy news.

Advocacy Update
·
1 Min Read

AMA on proposal to increase transparency in drug ads

While AMA is opposed to consumer advertising of prescription drugs, since the practice is allowed, ads should come with at least a small dose of transparency.

Press Releases
·
10 Min Read

Oct. 4, 2018: National Advocacy Update

Doctor office drug compounding oversight, OPPS and ASC proposed rule and more in the latest AMA national health care advocacy news.

Advocacy Update